Matches 1 - 50 out of 142 1 2 3 >


Match Document Document Title Score
D620976 Binder   1000
US20090134211 Method  
The present invention relates to a method for the provision of clinical trial products in the context of clinical trials.
1000
EP1894138A1 METHOD   1000
WO/2006/131544A1 METHOD  
The present invention relates to a method for the provision of clinical trial products in the context of clinical trials.
1000
WO/1996/017607A1 METHOD OF PRODUCING A PANTOPRAZOL LYOPHILISATE  
Disclosed is a method of producing a lyophilisate of pantoprazol sodium sesquihydrate, characterised by the lyophilisation of aqueous solutions of pantoprazol sodium sesquihydrate in the presence...
1000
5997903 Oral-administration forms of a medicament containing pantoprazol  
The invention relates to oral presentation forms for pantoprazole, which consist of a core, an intermediate layer and an outer layer which is resistant to gastric juice.
800
8754108 Freeze-dried pantoprazole preparation and pantoprazole injection  
Lyophilized pantoprazole preparations which are obtainable by freeze-drying of an aqueous solution of pantoprazole, ethylenediamine tetraacetic acid and/or a suitable salt thereof, and sodium...
800
US20080069882 Novel preparation and administration form comprising an acid-labile active compound  
Novel administration forms and preparation for acid-labile active compounds are described. The novel administration forms contain individual active compound units, the active compound being...
800
US20090093522 Freeze-dried pantoprazole preparation and pantoprazole injection  
Lyophilized pantoprazole preparations which are obtainable by freeze-drying of an aqueous solution of pantoprazole, ethylenediamine tetraacetic acid and/or a suitable salt thereof, and sodium...
800
6569453 Administration form comprising an acid-labile active compound  
An administration form for acid-labile active compounds are described. The administration forms have no enteric layers and are suitable for oral administration.
800
US20080226712 Oral administration form for pyridin-2-ylmethylsulfinyl-1H benzimidazoles  
The invention relates to an oral administration form for pyridin-2-ylmethylsulfinyl-1H-benzimidazoles and their salts, which comprises the active compound together with tablet disintegrants and is...
800
6132768 Oral pharmaceutical composition with delayed release of active ingredient for reversible proton pump inhibitors  
An oral pharmaceutical composition of a reversible proton pump inhibitor in pellet or tablet form, wherein the reversible proton pump inhibitor is at least partly in slow-release form, is...
800
6274173 Oral pharmaceutical composition with delayed release of active ingredient for pantoprazole  
An oral pharmaceutical composition comprises an acid-labile irreversible proton pump inhibitor in pellet or tablet form, wherein the irreversible proton pump inhibitor is at least partly in...
800
7357943 Pharmaceutical preparation in the form of a suspension comprising an acid-labile active ingredient  
The present invention relates to the field of pharmaceutical technology and describes a novel pharmaceutical preparation in the form of a suspension comprising an acid-labile active ingredient, in...
800
8465767 Oral administration form for pyridin-2-ylmethylsulfinyl-1H benzimidazoles  
The invention relates to an oral administration form for pyridin-2-ylmethylsulfinyl-1H-benzimidazoles and their salts, which comprises the active compound together with tablet disintegrants and is...
800
US20020025342 Novel administration form comprising an acid-labile active compound  
Novel administration form for acid-labile active compounds are described. The novel administration forms have no enteric layers and are suitable for oral administration.
800
7402321 Oral administration form for pyridin-2-ylmethylsulfinyl-1H-benzimidazoles  
The invention relates to an oral administration form for pyridin-2-ylmethylsulfinyl-1H-benzimidazoles and their salts, which comprises the active compound together with tablet disintegrants and is...
800
7785630 Preparation and administration form comprising an acid-labile active compound  
Novel administration forms and preparation for acid-labile active compounds are described. The novel administration forms contain individual active compound units, the active compound being...
800
5945124 Oral pharmaceutical composition with delayed release of active ingredient for pantoprazole  
An oral pharmaceutical composition of pantoprazole in pellet or tablet form, wherein the pantoprazole is at least partly in slow-release form, is distinguished, on combined administration with an...
800
6607742 Suppository composition which is a spray-dried suspension of an acid-labile proton pump inhibitor in a solvent solution of a sterol and polymer  
Acid-labile active compounds are prepared in suppository form, particularly for rectal administration.
800
US20040022854 Novel administration form comprising an acid-labile active compound  
Novel administration form for acid-labile active compounds are described. The novel administration forms have no enteric layers and are suitable for oral administration.
800
6780881 Freeze-dried pantoprazole preparation and pantoprazole injection  
Lyophilized pantoprazole preparations which are obtainable by freeze-drying of an aqueous solution of pantoprazole, ethylenediamine tetraacetic acid and/or a suitable salt thereof, and sodium...
800
US20030003058 Freeze-dried pantoprazole preparation and pantoprazole injection  
Lyophilized pantoprazole preparations which are obtainable by freeze-drying of an aqueous solution of pantoprazole, ethylenediamine tetraacetic acid and/or a suitable salt thereof, and sodium...
800
6383510 Suppository form comprising an acid-labile active compound  
Acid-labile active compounds are prepared in suppository form, particularly for rectal administration.
800
US20040101558 Pharmaceutical preparation in the form of a paste comprising an acid-labile active ingredient  
The present invention relates to the field of pharmaceutical technology and describes a pharmaceutical preparation in the form of a paste comprising an acid-labile active ingredient, in particular...
800
7351723 Freeze-dried pantoprazole preparation and pantoprazole injection  
Lyophilized pantoprazole preparations which are obtainable by freeze-drying of an aqueous solution of pantoprazole, ethylenediamine tetraacetic acid and/or a suitable salt thereof, and sodium...
800
US20040220228 Freeze-dried pantoprazole preparation and pantoprazole injection  
Lyophilized pantoprazole preparations which are obtainable by freeze-drying of an aqueous solution of pantoprazole, ethylenediamine tetraacetic acid and/or a suitable salt thereof, and sodium...
800
US20060263426 Oral administration form for pyridin-2-ylmethysulfinyl-1h-bezimidazoles  
The invention relates to an oral administration form for pyridin-2-ylmethylsulfinyl-1H-benzimidazoles and their salts, which comprises the active compound together with tablet disintegrants and is...
800
6068856 Oral pharmaceutical composition with delayed release of active ingredient for pantoprazole  
An oral pharmaceutical composition of pantoprazole in pellet or tablet form, wherein the pantoprazole is at least partly in slow-release form, is distinguished, on combined administration with an...
800
6884437 Administration form comprising an acid-labile active compound  
Novel administration forms for acid-labile active compounds are described. The novel administration forms have no enteric layers and are suitable for oral administration.
800
6328993 Oral administration form for an acid liable active proton pump inhibitor  
Novel administration form for acid-labile active compounds are described. The novel administration forms have no enteric layers and are suitable for oral administration.
800
US20020090397 Novel suppository form comprising an acid-labile active compound  
Acid-labile active compounds are prepared in suppository form, particularly for rectal administration.
800
7041313 Oral administration form for pyridin-2-ylmethylsulfinyl-1H-benzimidazoles  
The invention relates to an oral administration form for pyridin-2-ylmethylsulfinyl-1H-benzimidazoles and their salts, which comprises the active compound together with tablet disintegrants and is...
800
US20060127477 Novel preparation and administration form comprising an acid-labile active compound  
Novel administration forms and preparation for acid-labile active compounds are described. The novel administration forms contain individual active compound units, the active compound being...
800
7988999 Pharmaceutical preparation in the form of a paste comprising an acid-labile active ingredient  
The present invention relates to the field of pharmaceutical technology and describes a pharmaceutical preparation in the form of a paste comprising an acid-labile active ingredient, in particular...
800
US20040052832 Pharmaceutical preparation in the form of a supension comprising an acid-labile active ingredient  
The present invention relates to the field of pharmaceutical technology and describes a novel pharmaceutical preparation in the form of a suspension comprising an acid-labile active ingredient, in...
800
7790198 Preparation and administration form comprising an acid-labile active compound  
Novel administration forms and preparation for acid-labile active compounds are described. The novel administration forms contain individual active compound units, the active compound being...
800
7794752 Preparation and administration form comprising an acid-labile active compound  
Novel administration forms and preparations for acid-labile active compounds are described. The novel administration forms contain individual active compound units, the active compound being...
800
EP1037607A1 NOVEL SUPPOSITORY FORM COMPRISING AN ACID-LABILE ACTIVE COMPOUND  
Abstract not available for EP1037607 Abstract of corresponding document: WO9929320 Novel administration form for acid-labile active compounds are described. The novel administration forms have no...
800
EP1037634A1 ORAL ADMINISTRATION FORM COMPRISING A PROTON PUMP INHIBITOR (E.G.PANTOPRAZOLE)   800
EP1187601A1 NOVEL PREPARATION AND ADMINISTRATION FORM COMPRISING AN ACID-LABILE PROTON PUMP INHIBITOR  
Abstract not available for EP1187601 Abstract of corresponding document: EP1616562 Novel administration forms and preparations for acid-labile active compounds are described. The novel...
800
EP0589981B1 ORAL-ADMINISTRATION FORMS OF A MEDICAMENT CONTAINING PANTOPRAZOL  
Abstract not available for EP0589981 Abstract of corresponding document: US5997903 PCT No. PCT/EP92/01341 Sec. 371 Date Dec. 17, 1993 Sec. 102(e) Date Dec. 17, 1993 PCT Filed Jun. 13, 1992 PCT...
800
EP1105105A1 ORAL ADMINISTRATION FORM FOR PYRIDIN-2-YLMETHYLSULFINYL-1H-BENZIMIDAZOLES  
Abstract not available for EP1105105
800
EP1341523A1 PHARMACEUTICAL PREPARATION IN THE FORM OF A SUSPENSION COMPRISING AN ACID-LABILE ACTIVE INGREDIENT   800
EP0519365A1 Compositions for oral administration containing pantoprazole.  
The invention relates to compositions for oral administration containing pantoprazole which consist of a core, of an intermediate layer and of an enteric outer layer.
800
EP1105105B1 ORAL ADMINISTRATION FORM FOR PYRIDIN-2-YLMETHYLSULFINYL-1H-BENZIMIDAZOLES  
Abstract not available for EP1105105
800
EP1525882B1 Administration form comprising an acid-labile active compound   800
EP1525882A1 Administration form comprising an acid-labile active compound  
Abstract not available
800
EP1187601B1 NOVEL PREPARATION AND ADMINISTRATION FORM COMPRISING AN ACID-LABILE PROTON PUMP INHIBITOR  
Abstract not available for EP1187601 Abstract of corresponding document: EP1616562 Novel administration forms and preparations for acid-labile active compounds are described. The novel...
800
EP1341523B1 PHARMACEUTICAL PREPARATION IN THE FORM OF A SUSPENSION COMPRISING AN ACID-LABILE ACTIVE INGREDIENT   800

Matches 1 - 50 out of 142 1 2 3 >
« search again